![Venkat Ramanan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Venkat Ramanan
Director of Finance/CFO at
IMMATICS N.V.
Net worth: - $ as of 30/05/2026
Profile
Venkat Ramanan is currently Chief Financial Officer at Immatics NV since 2025.
Former positions include Chief Financial Officer at Turnstone Biologics Corp.
from 2022 to 2024, Chief Financial Officer at Anthos Therapeutics, Inc., and Senior Vice President-Finance at Seagen, Inc. Education includes a doctorate from The Ohio State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMATICS N.V. -.--% | 17/03/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Venkat Ramanan active positions
| Companies | Position | Start |
|---|---|---|
| IMMATICS N.V. | Director of Finance/CFO | 30/09/2025 |
Former positions of Venkat Ramanan
| Companies | Position | End |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Director of Finance/CFO | 24/10/2024 |
| SEAGEN INC. | Director of Finance/CFO | - |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Director of Finance/CFO | - |
Training of Venkat Ramanan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Turnstone Biologics Corp.
 Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
- Stock Market
- Insiders
- Venkat Ramanan
